A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes

Clinical trial NCT02942914 · COMPLETED

Trial details

NCT number: NCT02942914
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2016-12-20
Primary completion: 2017-10-18
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.